
Letrodyl 25mg Tablet
Marketer
UBM Pharmaceuticals
Salt Composition
Letrozole (25mg)
Overview Letrodyl 25mg Tablet
Postmenopausal women with breast cancer may find relief with Letrodyl 25mg tablets. This medication can be a standalone treatment or used alongside surgery or radiation therapy. In advanced cases, it helps prevent metastasis. Letrodyl 25mg can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage varies based on the specific application; your doctor will determine the appropriate amount for symptom management. Continue taking the medication for the prescribed period. Common side effects include sweating, tiredness, hot flashes, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, disclose any history of liver or kidney disease, or osteoporosis. Inform your doctor of all other medications you're taking, as interactions may affect Letrodyl's efficacy. Furthermore, inform your doctor if you are pregnant or breastfeeding. Pre- and ongoing monitoring of vitamin D levels and bone density may be conducted through blood tests.
Uses of Letrodyl 25mg Tablet
Managing breast cancer
Major Benefits of Letrodyl 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Letrodyl 25mg Tablets. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended for best results.
Common Side effects of Letrodyl 25mg Tablet:
- Dizziness
- Fatigue
- Weakness
- Bone pain
- Back pain
- Night sweats
- Joint pain
- Nausea
- Osteoporosis
- Joint inflammation
- Weight gain
- Hot flushes
- Edema (swelling)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Diaphoresis
- Bone fracture
- Hypercholesterolemia (high cholesterol)
- Cough
- Shortness of breath
How to use Letrodyl 25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 25mg Letrodyl tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.
How Letrodyl 25mg Tablet works:
Letrodyl 25mg tablets function as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. This lowered estrogen level can impede or halt the progression of certain estrogen-dependent breast cancers.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Letrodyl 25mg tablets poses no known adverse reactions.
PregnancyUNSAFE
Using Letrodyl 25mg tablets during pregnancy carries a high risk. Pregnant women should consult their physician; research in animal and human studies indicates substantial potential harm to the fetus.
Breast feedingUNSAFE
Using Letrodyl 25mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.
DrivingUNSAFE
Taking a 25mg Letrodyl tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Letrodyl 25mg Tablets is considered safe for individuals with kidney impairment, and no dosage modification is typically necessary. Limited data exists regarding its use in patients with terminal kidney disease; therefore, physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Letrodyl 25mg tablets cautiously. Dosage modification of Letrodyl 25mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Letrodyl 25mg Tablet :
Should you forget a Letrodyl 25mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Letrodyl 25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
